XenaLives
RE: None
Monday, February 14, 2022 2:39:28 PM
Post#
90
of 91
Historic short interest -
You can go to this link to check short interest in a stock:
http://nasdaqtrader.com/Trader.aspx?id=ShortInterest
Publication schedule is here:
http://nasdaqtrader.com/Trader.aspx?id=ShortIntPubSch
Settlement Date Short Interest Percent Change
Average Daily Share Volume Days to Cover
03/15/2022 128,075 (14.39) 47,132 2.72
02/28/2022 149,597 (13.52) 21,166 7.07
02/15/2022 172,991 (28.49) 42,199 4.10
01/31/2022 241,922 (46.03) 165,710 1.46
01/14/2022 448,233 (25.38) 346,134 1.29
12/31/2021 600,696 (51.92) 628,412 1.00
12/15/2021 1,249,480 47717.83 7,280,845 1.00
11/30/2021 2,613 (34.49) 22,632,999 1.00
11/15/2021 3,989 (95.41) 102,287 1.00
10/29/2021 86,964 7.22 26,424 3.29
10/15/2021 81,107 (0.08) 29,832 2.72
09/30/2021 81,168 (24.11) 20,302 4.00
09/15/2021 106,956 21.94 26,331 4.06
08/31/2021 87,712 (2.23) 26,402 3.32
08/13/2021 89,714 4.18 20,032 4.48
07/30/2021 86,114 (3.20) 19,243 4.48
07/15/2021 88,957 (18.41) 31,149 2.86
06/30/2021 109,027 3.41 21,339 5.11
06/15/2021 105,427 2.04 37,914 2.78
05/28/2021 103,316 2.20 29,626 3.49
05/14/2021 101,096 0.78 27,897 3.62
04/30/2021 100,312 (6.00) 21,561 4.65
04/15/2021 106,716 5.36 30,033 3.55
03/31/2021 101,286 (4.91) 24,409 4.15
03/15/2021 106,515 3.11 56,041 1.90
02/26/2021 103,304 2.54 76,050 1.36
02/12/2021 100,744 2.07 75,289 1.34
Recent CPIX News
- CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV® IN CHINA • PR Newswire (US) • 05/28/2026 01:05:00 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 05/26/2026 10:00:54 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2026 09:02:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 09:07:03 PM
- CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE • PR Newswire (US) • 05/05/2026 09:00:00 PM
- CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE • PR Newswire (US) • 04/28/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2026 09:08:24 PM
- Cumberland Pharmaceuticals jumps on $100M Apotex transaction • IH Market News • 04/23/2026 02:52:23 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/23/2026 01:02:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2026 01:01:32 PM
- Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex • PR Newswire (US) • 04/23/2026 01:00:00 PM
- RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026 • PR Newswire (US) • 04/22/2026 12:00:00 PM
- CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE • PR Newswire (US) • 04/16/2026 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:24:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:23:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:22:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:21:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:21:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:20:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:20:05 PM
- Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting • PR Newswire (US) • 03/17/2026 01:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/12/2026 09:00:17 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/09/2026 09:03:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 09:01:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 10:10:28 PM
